65,437 trials
Rheumatoid Arthritis
Primary: Percentage of Subjects Achieving American College of Rheumatology 20% (ACR20) Response — 342; 326; 309; 108 Participants — p=<0.0001
Breast Cancer
Primary: Progression-Free Survival (PFS) by Independent Review Committee (IRC) Assessment in Brain Metastasis Negative (BM-ve) Population — 5.6; 1.7 months — p=<0.0001
Healthy
Primary: Log Reduction of Bacterial Flora on the Abdomen and Groin — 1.9; 2.0; 1.3; 1.9 Log10 Reductions
Surgery
Primary: Log Reduction of Bacterial Flora on Abdomen and Groin Sites — 2.6; 3.4; 2.7; 4.2 Log 10 Reduction
Tetraplegia
Primary: Number of Participants With Patient Control Over the End Effector (Virtual or Physical) — 1 Participants
Prostatic Neoplasms, Castration-Resistant
Primary: Overall Survival (OS) — 15.2; 16.6 Months — p=0.0940
Hypogonadism
Primary: Corrected Area Under The Serum Concentration-time Profile From Time 0 to The Last Quantifiable Concentration (AUClast) of Total Testosterone (Part 1). — 1444; 1362…
Residual Neuromuscular Blockade
Primary: Mean Train-of-Four Ratios (TOFR's) — 0.97; 0.94; 0.96; 0.95 Ratio
Bariatric Surgery Candidate
Primary: Change in Serum CTX — 0.228 ng/ml
Stress and Burnout
Primary: Study Participant's Self-Rating of Likelihood to Leave Job in the Coming Year Over Time — 9; 13; 1; 5 Participants — p=0.18
Symptomatic Breast Lump
Primary: Number of Quadrants With Detected Breast Lesions — 77; 265 quadrants
Alzheimer's Disease · Frontotemporal Dementia, Behavioral Variant
Primary: Change in Clinical Disease Severity (CDR) — -0.1; 0.0; 0.0; 0.0 score on a scale
Laparoscopic Gastric Bypass Surgery · Ketamine
Primary: Total Cumulative Perioperative Opioid Dose — 179.9; 248.6 Morphine Equivalents — p=0.03
Tourette Syndrome
Primary: Frequency of Treatment-emergent Adverse Events (TEAEs) — 20; 29; 68 Participants
Phantom Limb Pain
Primary: "Average" Phantom Limb Pain Intensity 4 Weeks Following Initiation of an Ambulatory Continuous Peripheral Nerve Block (as Measured by the Numeric Rating Scale Within the…